PANalytical offers a wide range of key analytical techniques and products that are used in the pharmaceutical industry for research, development and quality control purposes. These rapid non-destructive analytical techniques such as near-infrared spectroscopy (NIR), X-ray diffraction (XRD) and X-ray fluorescence spectrometry (XRF) can be used for a large variety of (bio-)pharmaceutical applications including drug discovery, pre-formulation, formulation, stability testing and final product quality control.
PANalytical products and solutions provide the pharmaceutical industry with analysis methods for elaborate material characterization and also help the industry to meet strict regulatory requirements.
Speed, reproducibility, ease of use and the adherence to the demands of a highly regulated environment are key requirements for routine pharmaceutical applications. Many X-ray analytical tools have earned their place in today’s pharmaceutical development laboratories, especially in the areas of pre-formulation and formulation of solids. The non-destructive nature of the analyses often allows a multitude of process steps to be performed on the same sample without destroying its original structure.
Standardization and regulation have been embraced by the pharmaceutical community. Instruments used in this environment must provide secure operation, data validation and data traceability.
PANalytical offers a comprehensive portfolio of X-ray diffraction (XRPD) and X-ray fluorescence (XRF) instruments and related modules that are invaluable in areas of interest such as full characterization of active pharmaceutical ingredients (API), both small molecule and biologics, and excipients.
Rapid non-destructive characterization is possible for all material types, including fine chemicals, active pharmaceutical ingredients (API) (small molecules and biologics), excipients (organic and inorganic) and final drug products.
Internationally recognized pharmacopeial methods (both XRD and XRF) combined with technological developments such as ultra-fast, high-resolution detectors allow X-ray techniques to be at the forefront of (bio-)pharmaceutical development reducing analysis time while providing in-depth analysis of the sample.
PANalytical’s comprehensive expertise gives you an advantage:
PANalytical’s headquarters are in Almelo, the Netherlands. Fully equipped application laboratories are established in Japan, China, the US, Brazil, and the Netherlands. PANalytical is active in all but a few countries of the world. This worldwide sales and service network ensures unrivalled levels of customer support.
With a broad product portfolio and an extensive collection of patents and proprietary technologies, PANalytical continuously creates and sustains a distinct competitive advantage.
PANalytical is part of Spectris plc, the productivity-enhancing instrumentation and controls company.
7602 EA ALMELO
Tel.: +31 546 534444
Fax.: +31 546 534598